Viewing Study NCT01105403



Ignite Creation Date: 2024-05-05 @ 10:26 PM
Last Modification Date: 2024-10-26 @ 10:18 AM
Study NCT ID: NCT01105403
Status: COMPLETED
Last Update Posted: 2014-04-23
First Post: 2010-04-13

Brief Title: Exploratory Study on POL6326 in Stem Cell Mobilization
Sponsor: Polyphor Ltd
Organization: Polyphor Ltd

Study Overview

Official Title: A Phase IIa Proof of Concept Study is to Determine the Degree of Mobilisation of CD34 Cells Following Administration of POL6326 in Patients With Multiple Myeloma
Status: COMPLETED
Status Verified Date: 2014-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to determine whether POL6326 is safe and clinically active to mobilize hematopoietic stem cells followed by transplantation
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None